These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8090389)

  • 1. Safety of the new quinolones in pregnancy.
    Berkovitch M; Pastuszak A; Gazarian M; Lewis M; Koren G
    Obstet Gynecol; 1994 Oct; 84(4):535-8. PubMed ID: 8090389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the new quinolones during pregnancy.
    Koren G
    Can Fam Physician; 1996 Jun; 42():1097-9. PubMed ID: 8704483
    [No Abstract]   [Full Text] [Related]  

  • 3. Pregnancy outcome post renal transplantation.
    Sgro MD; Barozzino T; Mirghani HM; Sermer M; Moscato L; Akoury H; Koren G; Chitayat DA
    Teratology; 2002 Jan; 65(1):5-9. PubMed ID: 11835226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Birth defects in a cohort of uninfected children born to HIV-infected women].
    Fernández Ibieta M; Ramos Amador JT; Bellón Cano JM; González-Tomé MI; Guillén Martín S; Navarro Gómez M; de José MI; Beceiro J; Iglesias E; Prieto L; Santos MJ; Martínez Guardia N; Roa MA; Regidor J
    An Pediatr (Barc); 2009 Mar; 70(3):253-64. PubMed ID: 19246263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal urinary tract infection and related drug treatments during pregnancy and risk of congenital abnormalities in the offspring.
    Bánhidy F; Acs N; Puhó EH; Czeizel AE
    BJOG; 2006 Dec; 113(12):1465-71. PubMed ID: 17083651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: a prospective cohort study.
    Lee SW; Han JY; Choi JS; Chung JH; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
    Reprod Toxicol; 2009 Apr; 27(2):196-8. PubMed ID: 19162171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group.
    Costedoat-Chalumeau N; Amoura Z; Duhaut P; Huong DL; Sebbough D; Wechsler B; Vauthier D; Denjoy I; Lupoglazoff JM; Piette JC
    Arthritis Rheum; 2003 Nov; 48(11):3207-11. PubMed ID: 14613284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester exposure to amoxycillin/clavulanic acid: a prospective, controlled study.
    Berkovitch M; Diav-Citrin O; Greenberg R; Cohen M; Bulkowstein M; Shechtman S; Bortnik O; Arnon J; Ornoy A
    Br J Clin Pharmacol; 2004 Sep; 58(3):298-302. PubMed ID: 15327589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy, delivery, and outcome for the child in maternal epilepsy.
    Veiby G; Daltveit AK; Engelsen BA; Gilhus NE
    Epilepsia; 2009 Sep; 50(9):2130-9. PubMed ID: 19490036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study.
    Diav-Citrin O; Shechtman S; Gotteiner T; Arnon J; Ornoy A
    Teratology; 2001 May; 63(5):186-92. PubMed ID: 11320529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study.
    Nørgaard M; Pedersen L; Gislum M; Erichsen R; Søgaard KK; Schønheyder HC; Sørensen HT
    J Antimicrob Chemother; 2008 Jul; 62(1):172-6. PubMed ID: 18400803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teratogenic study of doxycycline.
    Czeizel AE; Rockenbauer M
    Obstet Gynecol; 1997 Apr; 89(4):524-8. PubMed ID: 9083306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study.
    Diav-Citrin O; Okotore B; Lucarelli K; Koren G
    Am J Perinatol; 1999; 16(4):157-60. PubMed ID: 10458526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible association between different congenital abnormalities and use of different sulfonamides during pregnancy.
    Czeizel AE; Puhó E; Sørensen HT; Olsen J
    Congenit Anom (Kyoto); 2004 Jun; 44(2):79-86. PubMed ID: 15198720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of substance abuse during pregnancy and infant outcome.
    Little BB; Snell LM; Van Beveren TT; Crowell RB; Trayler S; Johnston WL
    Am J Perinatol; 2003 Jul; 20(5):255-62. PubMed ID: 13680509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.
    Bar-Oz B; Diav-Citrin O; Shechtman S; Tellem R; Arnon J; Francetic I; Berkovitch M; Ornoy A
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):31-4. PubMed ID: 18760873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort.
    Boskovic R; Wide R; Wolpin J; Bauer DJ; Koren G
    Neurology; 2005 Sep; 65(6):807-11. PubMed ID: 16186517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of birth defects associated with nelfinavir exposure during pregnancy.
    Covington DL; Conner SD; Doi PA; Swinson J; Daniels EM
    Obstet Gynecol; 2004 Jun; 103(6):1181-9. PubMed ID: 15172850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity.
    Schaefer C
    Birth Defects Res A Clin Mol Teratol; 2003 Aug; 67(8):591-4. PubMed ID: 14632309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based case-control teratologic study of furazidine, a nitrofuran-derivative treatment during pregnancy.
    Czeizel AE; Rockenbauer M; Sørensen HT; Olsen J
    Clin Nephrol; 2000 Apr; 53(4):257-63. PubMed ID: 10809412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.